Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Condensed Consolidated Statements of Operations and Comprehensive Loss
Grant revenue	$ 561,574	$ 249,688	$ 942,143	$ 249,688
Operating expenses:
Research and development	2,557,679	2,202,657	4,158,052	3,459,199
General and administrative	1,850,819	1,698,712	3,780,685	5,064,673
Total operating expenses	4,408,498	3,901,369	7,938,737	8,523,872
Loss from operations	(3,846,924)	(3,651,681)	(6,996,594)	(8,274,184)
Other income (expense):
Interest income, net	382,374	336,221	665,777	592,631
Foreign currency (loss) gain	(5,502)	56,363	50,674	42,566
Total other income	376,872	392,584	716,451	635,197
Net loss	(3,470,052)	(3,259,097)	(6,280,143)	(7,638,987)
Other comprehensive (loss):
Foreign currency translation	(1,948)	(73,420)	(17,031)	(11,464)
Total comprehensive loss	$ (3,472,000)	$ (3,332,517)	$ (6,297,174)	$ (7,650,451)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.58)	$ (0.87)	$ (1.24)	$ (2.18)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.58)	$ (0.87)	$ (1.24)	$ (2.18)
Weighted-average common shares outstanding, basic (in shares)	5,937,291	3,731,571	5,067,809	3,497,329
Weighted-average common shares outstanding, diluted (in shares)	5,937,291	3,731,571	5,067,809	3,497,329